Detalles de la búsqueda
1.
Satisfaction of Patients Who Received Breast-Conserving Surgery Using the Suture Scaffold Technique: A Single-Institution, Cross-Sectional Study.
Ann Surg Oncol;
29(6): 3829-3835, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35275329
2.
Anthracycline-containing regimens or taxane versus S-1 as first-line chemotherapy for metastatic breast cancer.
Br J Cancer;
125(9): 1217-1225, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34480096
3.
Factors affecting enrollment in randomized controlled trials conducted for patients with metastatic breast cancer.
Jpn J Clin Oncol;
50(8): 873-881, 2020 Aug 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32463090
4.
Diffuse distribution of tumor-infiltrating lymphocytes is a marker for better prognosis and chemotherapeutic effect in triple-negative breast cancer.
Breast Cancer Res Treat;
178(2): 283-294, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31402409
5.
Circulating tumor cells as a prognostic marker for efficacy in the randomized phase III JO21095 trial in Japanese patients with HER2-negative metastatic breast cancer.
Breast Cancer Res Treat;
162(3): 501-510, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28181129
6.
ASO Author Reflections: Patients' Satisfaction After Breast Conserving Surgery Using the Suture Scaffold Technique.
Ann Surg Oncol;
29(6): 3836-3837, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35266082
7.
Cost-effectiveness analysis of the introduction of S-1 therapy for first-line metastatic breast cancer treatment in Japan: results from the randomized phase III SELECT BC trial.
BMC Cancer;
17(1): 773, 2017 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-29149882
8.
Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trial.
Lancet Oncol;
17(1): 90-8, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26617202
9.
Prognostic and predictive impacts of tumor-infiltrating lymphocytes differ between Triple-negative and HER2-positive breast cancers treated with standard systemic therapies.
Breast Cancer Res Treat;
158(1): 1-9, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27260189
10.
Efficacy and safety of an amino acid jelly containing coenzyme Q10 and L-carnitine in controlling fatigue in breast cancer patients receiving chemotherapy: a multi-institutional, randomized, exploratory trial (JORTC-CAM01).
Support Care Cancer;
24(2): 637-646, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26105516
11.
Long-term prognostic value of the GenesWell BCT score in Asian women with hormone receptor-positive/HER2-negative early breast cancer.
Breast Cancer;
31(1): 31-41, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37812303
12.
The Clinicopathological and Prognostic Significance of HER2-Low Breast Cancer: A Comparative Analysis Between HER2-Low and HER2-Zero Subtypes.
Clin Breast Cancer;
2024 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38472058
13.
The efficacy and safety of FSK0808, filgrastim biosimilar: a multicenter, non-randomized study in Japanese patients with breast cancer.
Jpn J Clin Oncol;
43(9): 865-73, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23858037
14.
Combined Use of Texture Features and Morphological Classification Based on Dynamic Contrast-enhanced MR Imaging: Differentiating Benign and Malignant Breast Masses with High Negative Predictive Value.
Magn Reson Med Sci;
21(3): 485-498, 2022 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34176860
15.
Aldehyde dehydrogenase 1 expression is a predictor of poor prognosis in node-positive breast cancers: a long-term follow-up study.
Histopathology;
58(4): 608-16, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21371077
16.
Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer.
Histopathology;
59(4): 776-80, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22014057
17.
[A patient with of metastatic breast cancer with a well-controlled quality of life using S-1 therapy as first-line chemotherapy].
Gan To Kagaku Ryoho;
38(4): 635-7, 2011 Apr.
Artículo
en Japonés
| MEDLINE | ID: mdl-21498994
18.
Circulating microRNA Panel as a Potential Novel Biomarker for Oral Squamous Cell Carcinoma Diagnosis.
Cancers (Basel);
13(3)2021 Jan 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33504017
19.
Correlation between 18F-FDG uptake on PET/MRI and the level of tumor-infiltrating lymphocytes (TILs) in triple-negative and HER2-positive breast cancer.
Eur J Radiol;
123: 108773, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31918248
20.
Artificial intelligence for breast cancer detection in mammography: experience of use of the ScreenPoint Medical Transpara system in 310 Japanese women.
Breast Cancer;
27(4): 642-651, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32052311